Results 251 to 260 of about 229,170 (307)

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Inclusion of health equity variables in UK national anaesthesia projects. [PDF]

Anaesthesia
Hudson S, Shah A, Kudsk-Iversen S, Kudsk-Iversen S.   +3 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Interprofessional Education as a Sandbox for Collaborative Play-Towards Health Equity. [PDF]

Clin Teach
Versluis MAC, Jensen G, de Carvalho-Filho MA, Durning SJ.   +3 more
europepmc   +1 more source

Prevention is Resistance: Upholding LGBTQIA+ Health Equity in the Era of Retrenchment. [PDF]

Dela J Public Health
Abdallah S.
europepmc   +1 more source

Challenges and Opportunities for Paving the Road to Global Health Equity Through Implementation Science

Prajakta Adsul, Rachel C. Shelton, April Oh, Nathalie Moise, Juliet Iwelunmor, Derek M. Griffith   +5 more
openalex   +1 more source